Home News Featured Announcements: Products of Many Companies Included in the New Version of the New Coronary Pneumonia Diagnosis and Treatment Program_ Securities Times Network

Featured Announcements: Products of Many Companies Included in the New Version of the New Coronary Pneumonia Diagnosis and Treatment Program_ Securities Times Network

by admin
Featured Announcements: Products of Many Companies Included in the New Version of the New Coronary Pneumonia Diagnosis and Treatment Program_ Securities Times Network
</p> <p> Featured Announcements: Products of Many Companies Included in the New Version of the New Coronary Pneumonia Diagnosis and Treatment Program_ Securities Times Network<br /> news.google.com/__i/rss/rd/articles/images/public.css” />news.google.com/__i/rss/rd/articles/images/share_style0_16.css” />

news.google.com/__i/rss/rd/articles/images/css1.css” rel=”stylesheet” type=”text/css” />

Home > News > e company

Announcement Featured: Products of many companies are included in the new version of the new coronary pneumonia diagnosis and treatment plan

2022-03-17 20:41

Source: Securities Times e Company

Author: Zheng Zaojin

Securities Times · e company

Zheng Zaojin

2022-03-17 20:41

Securities Times e-company news, Yiling Pharmaceutical: Lianhua Qingwen Capsules (granules) are included in the “New Coronavirus Pneumonia Diagnosis and Treatment Program (Trial Ninth Edition)”; Kangyuan Pharmaceutical: Reduning Injection, etc. are included in the new Diagnosis and Treatment Plan for Coronavirus Pneumonia (Trial Version 9); Taiji Group: Angong Niuhuang Pills, etc. are included in the Diagnosis and Treatment Plan for Novel Coronavirus Pneumonia (Trial Version 9); Yisheng Pharmaceutical: The company’s products are listed in the “Diagnosis and Treatment of Novel Coronavirus Pneumonia” Plan (Trial Version 9)”; Kain Technology: The new coronavirus research projects KW-041 and KW-043 are both in the preclinical research stage; Zenda Essence: the company’s chairman and board secretary are assisting the relevant authorities to investigate; Chip International: Acting Chairman Gao Yonggang was appointed as Chairman; Shenhuo Co., Ltd. performance report: Net profit in 2021 was 3.281 billion yuan, an increase of 815.61% year-on-year; China Mining Resources: Net profit from January to February increased by about 1170.12% year-on-year; Qilianshan: controlling shareholder It is planned to increase the company’s shares by 120 million yuan to 150 million yuan; Tianhai Defense: The subsidiary plans to sign a bulk carrier construction contract of about 747 million yuan; On-machine CNC: Sign a long-term sales contract for monocrystalline silicon wafers of about 4.3 billion yuan; Xinwang Da: It is planned to build a 20GWh power battery and energy storage battery production base with 8 billion yuan.

Disclaimer: Securities Times strives for true and accurate information. The content mentioned in the article is for reference only and does not constitute substantive investment advice. Operational risks are based on this.

  • Securities Times APP
  • WeChat public account


  • 4252581

    Announcement Featured: Products of many companies are included in the new version of the new coronary pneumonia diagnosis and treatment plan

    6885

    e company

    news

    1445

    Zheng Zaojin

    2022-03-17

    See also  Letta: "Internships and precariousness are the great problem of the country, well a pact for work"

    You may also like

    Leave a Comment

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

    Privacy & Cookies Policy